M A Morozova - JoVE Visualize

Showing results (41-50 of 48) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 48 results.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 19, 2014

[The use of acatinol in the treatment of stable patients with schizophrenia with predominance of behaviour disorganization and subcatatonic features]M A Morozova, G E Rupchev, I G Kozhekin, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 22, 2024

[The technology of induction of physiological ketosis in asthenia of various origins and decreased resistance to cognitive and physical activity]M A Morozova, A G Beniashvili, G P Kostyuk, et al.

Thescientificworldjournal|June 1, 2018

The DNA of Bacteria of the World Ocean and the Earth in Cosmic Dust at the International Space StationT V Grebennikova, A V Syroeshkin, E V Shubralova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 29, 2022

[Low doses of quetiapine (Seroquel) as an impulsivity corrector in patients with bipolar affective disorder in remission]M A Morozova, S S Potanin, D S Burminskiy, et al.

Terapevticheskii Arkhiv|October 26, 2022

[The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial]A D Kulagin, B A Bakirov, I L Davydkin, et al.

HLA|February 4, 2025

Detection and Quantification of Polymorphic MICA and MICB Molecules in Immunoassays: Initial InsightsA Yu Stolbovaya, A A Pinevich, I V Gryazeva, et al.

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|August 29, 2001

[Levels and molecular heterogeneity of serotonin transporter protein in platelets of patients with different mental diseases: a comparative analysis with the use of monoclonal and polyclonal antibodies]O S Brusov, M I Faktor, G P Zlobina, et al.

Doklady. Biochemistry and Biophysics|May 12, 2025

The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTAE L Nasonov, V I Mazurov, A M Lila, et al.

Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 48 results.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 19, 2014

[The use of acatinol in the treatment of stable patients with schizophrenia with predominance of behaviour disorganization and subcatatonic features]M A Morozova, G E Rupchev, I G Kozhekin, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 22, 2024

[The technology of induction of physiological ketosis in asthenia of various origins and decreased resistance to cognitive and physical activity]M A Morozova, A G Beniashvili, G P Kostyuk, et al.

Thescientificworldjournal|June 1, 2018

The DNA of Bacteria of the World Ocean and the Earth in Cosmic Dust at the International Space StationT V Grebennikova, A V Syroeshkin, E V Shubralova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 29, 2022

[Low doses of quetiapine (Seroquel) as an impulsivity corrector in patients with bipolar affective disorder in remission]M A Morozova, S S Potanin, D S Burminskiy, et al.

Terapevticheskii Arkhiv|October 26, 2022

[The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial]A D Kulagin, B A Bakirov, I L Davydkin, et al.

HLA|February 4, 2025

Detection and Quantification of Polymorphic MICA and MICB Molecules in Immunoassays: Initial InsightsA Yu Stolbovaya, A A Pinevich, I V Gryazeva, et al.

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|August 29, 2001

[Levels and molecular heterogeneity of serotonin transporter protein in platelets of patients with different mental diseases: a comparative analysis with the use of monoclonal and polyclonal antibodies]O S Brusov, M I Faktor, G P Zlobina, et al.

Doklady. Biochemistry and Biophysics|May 12, 2025

The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTAE L Nasonov, V I Mazurov, A M Lila, et al.

Pageof 5